Showing results (1901-1910 of 2,722) with videos related to
Sort By:
Pageof 273
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 12, 2024
Understanding long-term risk in Percutaneous Coronary Intervention (PCI) in the Australian contemporary era with a focus on defining Complex Revascularisation in High-Risk Indicated Patients (CHIP)Julian Yeoh, Garry W Hamilton, Diem Dinh, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 13, 2024
Trends in coronary artery disease mortality among adults with diabetes: Insights from CDC WONDER (1999-2020)Muhammad Abdullah Naveed, Ahila Ali, Sivaram Neppala, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 30, 2024
Surviving venoarterial extracorporeal membrane oxygenation (VA-ECMO): The roles of severity scores and post-operative lactate clearanceAsem Ayyad, Raef Fadel, Patrick Kollman, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 18, 2025
Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve replacement: A network meta-analysisPedro E P Carvalho, Bruno Ramos Nascimento, Douglas M Gewehr, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 14, 2025
Risk of acute kidney injury after percutaneous coronary intervention with plaque modificationSant Kumar, Kathleen E Kearney, Christine J Chung, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 9, 2024
Angiographic and clinical impact of balloon inflation time in percutaneous coronary interventions with sirolimus-coated balloon: A subanalysis of the EASTBOURNE studyFilippo Luca Gurgoglione, Dario Gattuso, Antonio Greco, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 22, 2024
The impact of stress testing to guide PCI in patients with chronic coronary diseaseGarry W Hamilton, Anoop N Koshy, Diem Dinh, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 2, 2024
Peripheral intravascular lithotripsy to facilitate transfemoral transcatheter aortic valve replacement - Defining optimal treatable peripheral arterial disease burdenStephanie Tom, Andy Tully, Yuta Kikuchi, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 1, 2024
Transcatheter aortic valve replacement outcomes in patients with high gradient versus low ejection fraction low gradient severe aortic stenosis: A meta-analysis of randomized controlled trialsAsseel Al-Bayati, Abdullah Alrifai, Fahed Darmoch, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 25, 2024
Relationships between sex and in-hospital outcomes of patients with acute cardiogenic shock receiving mechanical circulatory supportNadhem Abdallah, Abdilahi Mohamoud, Talal Almasri, et al.Pageof 273